Rockwell Medical (RMTI) Capital Leases (2010 - 2026)

Rockwell Medical (RMTI) has reported Capital Leases for 8 consecutive years, with $99000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Leases fell 83.88% year-over-year to $99000.0; the trailing twelve-month figure through Jun 2026 stood at $99000.0 (down 83.88% YoY), and the FY2025 full-year result was $304000.0, down 67.35% from the prior year.
• Capital Leases slipped to $99000.0 in Q2 2026 per RMTI's latest filing, from $190000.0 in the prior quarter.
• Across five years, Capital Leases topped out at $2.1 million in Q4 2022 and bottomed at $99000.0 in Q2 2026.
• Historically, Capital Leases has averaged $1.1 million across 5 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Capital Leases retreated 26.72% in 2023, then slumped 83.88% in 2026.
• Over 5 years, Capital Leases stood at $2.1 million in 2022, then dropped by 26.72% to $1.5 million in 2023, then slumped by 39.15% to $931000.0 in 2024, then slumped by 67.35% to $304000.0 in 2025, then slumped by 67.43% to $99000.0 in 2026.
• According to Business Quant data, Capital Leases over the past three periods registered $99000.0, $190000.0, and $304000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.